Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
[Efficacy and safety of antiCD20 monoclonal antibody divozilimab during 48-week treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(7. Vyp. 2):43-52. doi: 10.17116/jnevro202312307243.
Zh Nevrol Psikhiatr Im S S Korsakova. 2023.
PMID: 37560833
Clinical Trial.
Russian.
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
Gusev EI, Martynov MY, Nikonov AA, Shamalov NA, Semenov MP, Gerasimets EA, Yarovaya EB, Semenov AM, Archakov AI, Markin SS; FRIDA Study Group.
Gusev EI, et al.
Lancet Neurol. 2021 Sep;20(9):721-728. doi: 10.1016/S1474-4422(21)00210-6.
Lancet Neurol. 2021.
PMID: 34418399
Clinical Trial.
Item in Clipboard
[The remote results of treatment of ischemic stroke conditioned by atherosclerotic affection of carotid arteries].
Kovalenko IB, Chefranova JY, Poliansky VD, Zuyeva NS, Lykov YA.
Kovalenko IB, et al. Among authors: chefranova jy.
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2019 Nov;27(6):1049-1052. doi: 10.32687/0869-866X-2019-27-6-1049-1052.
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2019.
PMID: 31884766
Russian.
Item in Clipboard
[Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS].
Boyko AN, Alifirova VM, Lukashevich IG, Goncharova ZA, Greshnova IV, Zaslavsky LG, Kotov SV, Malkova NA, Mishin GN, Parshina EV, Poverennova IY, Prakhova LN, Sivertseva SA, Smagina IV, Totolyan NA, Trinitatsky YV, Trushnikova TN, Khabirov FA, Chefranova JY, Shchur SG, Dudin VA, Pokhabov DV, Artemeva AV, Eremeeva AV, Linkova YN, Zinkina-Orikhan AV.
Boyko AN, et al. Among authors: chefranova jy.
Zh Nevrol Psikhiatr Im S S Korsakova. 2024;124(4):86-96. doi: 10.17116/jnevro202412404186.
Zh Nevrol Psikhiatr Im S S Korsakova. 2024.
PMID: 38676683
Clinical Trial.
Russian.
Item in Clipboard
Cite
Cite